Tygh Capital Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$1.18M Sell
25,831
-4,889
-16% -$255K 0.15% 82
2021
Q3
$1.95M Buy
+30,720
New +$2.34M 0.26% 85

Other funds holding CDNA

Tygh Capital Management's CDNA Position: Q4 2021 in Review

Tygh Capital Management reduced its CareDx (CDNA) stake by 16% in Q4 2021, selling an estimated $255K and leaving 25,831 shares worth $1.18M. The position accounts for 0.15% of the portfolio, ranked #82.

Tygh Capital Management first reported a position in CDNA in Q3 2021 and has held it in 2 quarters since. The position peaked at $1.95M in Q3 2021. 224 funds tracked by Wall St. Rank hold CDNA as of Q4 2021.

  • Tygh Capital Management held 25,831 shares of CareDx worth $1.18M as of Q4 2021.
  • Tygh Capital Management sold 4,889 CareDx shares in Q4 2021, an estimated $255K.
  • CareDx made up 0.15% of Tygh Capital Management's portfolio in Q4 2021, its #82 holding.
  • Tygh Capital Management first reported a position in CareDx in Q3 2021 and has held it in 2 quarters since.
  • Tygh Capital Management's CareDx position peaked at $1.95M in Q3 2021.
  • 224 funds tracked by Wall St. Rank held CareDx as of Q4 2021.

Based on Tygh Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.